Get the tools used by (smart)2 investors.
SP500 2.1%DOW 1.6%FTSE 100 1.1%NIKKEI 0.7%OIL 0.9%GOLD 0.0%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EV / EBITA for Ainos Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AIMD: Ainos Inc

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antige...

0.52 USD
Price
– USD
Fair Value
–
Upside
0.40 - 1.50
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Ainos Inc's EV / EBITA:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-50.0x-40.0x-30.0x-20.0x-10.0x
Performance Summary
  • Ainos's latest twelve months ev / ebita is -1.7x
  • Ainos's ev / ebita for fiscal years ending December 2020 to 2024 averaged -10.6x.
  • Ainos's operated at median ev / ebita of -2.2x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Ainos's ev / ebita peaked in December 2022 at -1.0x.
  • Ainos's ev / ebita hit its 5-year low in December 2021 of -42.3x.
  • Ainos's ev / ebita decreased in 2021 (-42.3x, +661.0%) and 2023 (-2.2x, +115.5%) and increased in 2020 (-5.6x, -22.8%), 2022 (-1.0x, -97.6%), and 2024 (-1.7x, -19.3%).

How does Ainos's EV / EBITA benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Ainos Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Ainos EV / EBITA Benchmarks
NameTickerEV / EBITA
America Great HealthOTCPK:AAGH-16.5x
XOMA CorpNASDAQGM:XOMA-14.3x
Cytokinetics IncNASDAQGS:CYTK-9.2x
INmune Bio IncNASDAQCM:INMB-3.5x
Sera Prognostics IncNASDAQGM:SERA-1.9x
Karyopharm Therapeutics IncNASDAQGS:KPTI-1.8x
Ainos IncOTCPK:AIMD-1.7x
Neurogene IncNASDAQGM:NGNE-1.6x
Curis IncNASDAQCM:CRIS-0.9x
HealthcareSECTOR:HLTH.US-0.6x
I MabNASDAQGM:IMAB1.7x
Spero Therapeutics IncNASDAQGS:SPRO26.3x

Metric Usage: EV / EBITA

Hide this widget
ev_to_ebita_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EV / EBITA in the valuation category include:

View Full List

Search for metric or datapoint

EV / EBITA

Measures the dollars in Enterprise Value for each dollar of EBITA over the last twelve months.

Definition of EV / EBITA

Hide this widget
Measures the dollars in Enterprise Value for each dollar of EBITA over the last twelve months.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-85.9x-40.9x4.1x93.1x0200400600

The chart above depicts the distribution of ev / ebita for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,364 had meaningful values. The average ev / ebita of companies in the sector is 0.3x with a standard deviation of 17.0x.

Ainos Inc's EV / EBITA of -1.7x ranks in the 41.9% percentile for the sector. The following table provides additional summary stats:

EV / EBITA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,462
Included Constituents2,364
Min-87.2x
Max91.1x
Median-0.8x
Mean0.3x
Standard Deviation17.0x

You can find companies with similar ev / ebita using this stock screener.

All rights reserved. Terms Of Use